ALLOSTEROS

allosteros-logo

Allosteros Therapeutics Inc. engages in discovery and development of breakthrough small molecule drugs that target allosteric sites on key proteins in disease pathways. Allosteros Therapeutics Inc. was incorporated in 2009 and is based in Palo Alto, California.

#SimilarOrganizations #People #Financial #More

ALLOSTEROS

Social Links:

Industry:
Biotechnology Clinical Trials Medical Device Pharmaceutical Therapeutics

Founded:
2009-01-01

Address:
Palo Alto, California, United States

Country:
United States

Total Employee:
1+

Status:
Active

Total Funding:
1.29 M USD


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

indel-therapeutics-logo

Indel Therapeutics

Indel Therapeutics is engaged in the development of new drugs to address the global health crisis caused by antibiotic resistance.

macuclear-logo

MacuCLEAR

MacuCLEAR focuses on discovering and developing novel solutions for vascular disorders of the eye.

nuovo-biologics-logo

Nuovo Biologics

Nuovo Biologics is engaged in the research and development of animal health products.

postsurgical-therapeuticsthera-logo

Postsurgical Therapeuticsthera

Postsurgical Therapeutics Inc. is a biotech firm developing a unique drug delivery system using polylactic glycolic acid.

not_available_image

Roche Laboratories

Roche Laboratories, Inc. engages in the marketing and sale of pharmaceutical medications


Current Advisors List

christopher-de-souza_image

Christopher de Souza Board Observer @ Allosteros
Board_observer

Current Employees Featured

mark-anderson_image

Mark Anderson
Mark Anderson Co-Founder @ Allosteros
Co-Founder

howard-schulman_image

Howard Schulman
Howard Schulman Founder, President and CSO @ Allosteros
Founder, President and CSO
2010-01-01

Founder


howard-schulman_image

Howard Schulman

mark-anderson_image

Mark Anderson

Investors List

broadview-ventures_image

Broadview Ventures

Broadview Ventures investment in Seed Round - Allosteros

More informations about "Allosteros"

Allosteros - Crunchbase Company Profile & Funding

Organization. Allosteros . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About. ... Allosteros Therapeutics Inc. engages in discovery and โ€ฆSee details»

Allosteros - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... obfuscated. obfuscated โ€” Mar 25, 2010: Seed Round - Allosteros . 1: โ€ฆSee details»

Allosteros Therapeutics - Broadview Ventures

Allosteros Therapeutics, Inc. was a drug discovery company developing novel, potent, and selective small molecule of a critical signaling pathway that promotes heart disease.Inhibitors โ€ฆSee details»

Allosteros Therapeutics Inc. Company Profile | Sunnyvale, CA ...

Find company research, competitor information, contact details & financial data for Allosteros Therapeutics Inc. of Sunnyvale, CA. Get the latest business insights from Dun & Bradstreet.See details»

ALLOSTEROS THERAPEUTICS, INC. - VentureRadar

Allosteros Therapeutics, Inc. is a drug discovery company has developed novel, potent, and selective small molecule of a critical signaling pathway that promotes heart disease. Inhibitors โ€ฆSee details»

Allosteros Therapeutics - PitchBook

Allosteros Therapeutics General Information Description. Developer of targeting drugs designed to target key proteins in cardiovascular disease signaling pathways. The company's drugs are โ€ฆSee details»

Allosteros Therapeutics - Products, Competitors, Financials, โ€ฆ

Headquarters Location. 560 Pena Court . Palo Alto, California, 94306, United States. 650-644-7559See details»

Allosteros Therapeutics Inc - Company Profile and News

Company profile page for Allosteros Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»

Allosteros - Crunchbase

Allosteros Therapeutics Inc. engages in discovery and development of breakthrough small molecule drugs.See details»

LTP expression mediated by autonomous activity of GluN2B

Oct 22, 2024 The CaMKII inhibitors AS100283 and AS100397 (here referred to as AS283 and AS397) were developed by Allosteros Therapeutics, Inc., and a stock supply was synthesized โ€ฆSee details»

Abstract 14868: Identification of Novel Small Molecule Inhibitors โ€ฆ

Oct 30, 2022 Allosteros Therapeutics Inc, Vasa Therapeutics, Inc., Sunnyvale, CA. View all articles by this author. Bheema Paraselli. Chemveda Life Sciences India Private Limited, โ€ฆSee details»

AlloFinder: a strategy for allosteric modulator discovery and ...

Jul 2, 2018 INTRODUCTION. Allostery, or allosteric regulation, underlies a plethora of biological processes, encompassing cellular metabolism, enzyme catalysis, gene expression and โ€ฆSee details»

CaMKII inhibitors: from research tools to therapeutic agents

Feb 19, 2014 Allosteros Therapeutics, Inc., Sunnyvale, CA, USA ... CaMKII domain organization and schematic of activation states. One subunit of a holoenzyme composed of hub and bi โ€ฆSee details»

Allosteros - Contacts, Employees, Board Members, Advisors

Organization. Allosteros . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 2. ... Allosteros has 1 board member โ€ฆSee details»

Ca2+/Calmodulin-Dependent Kinase IIฮด Causes Heart Failure by ...

Aug 16, 2010 Dr Anderson is named on patents claiming to treat heart failure by CaMKII inhibition and is a cofounder of Allosteros. The other authors report no conflicts. CLINICAL โ€ฆSee details»

Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs

Sep 15, 2022 Here, we discuss the principles of allosteric activating mutations, propagation downstream of the signals that they prompt, and allosteric drugs, with examples from the Ras โ€ฆSee details»

What is allosteric regulation? Exploring the exceptions that prove โ€ฆ

Mar 1, 2024 โ€œAllostericโ€ was first introduced to mean the other site (i.e., a site distinct from the active or orthosteric site), an adjective for โ€œregulationโ€ to imply a regulatory outcome resulting โ€ฆSee details»

Mark Anderson - Co-Founder @ Allosteros - Crunchbase

Primary Organization . Allosteros . Location Palo Alto, California, United States; ... Mark E. Anderson is a Co-Founder of Allosteros. He previously worked as the Betty and Jack Bailey โ€ฆSee details»

Allostery in Drug Development - PubMed

Allosteric regulation is a ubiquitous strategy employed in nature to control cellular processes by regulating the affinities of biomolecules. Allosteric modulators are able to tune the โ€ฆSee details»

What is allosteric regulation? Exploring the exceptions that prove โ€ฆ

Jan 23, 2024 โ€œAllostericโ€ was first introduced to mean the other site (i.e., a site distinct from the active or orthosteric site), an adjective for โ€œregulationโ€ to imply a regulatory outcome resulting โ€ฆSee details»

linkstock.net © 2022. All rights reserved